Home » Topics » BioWorld Science

BioWorld Science
RSS

Sichuan Kelun-Biotech Biopharmaceutical presents ARG1-targeting PROTACs

Dec. 4, 2019

FDA accepts IND for phase I trial of SKL-24741 for epilepsy

Dec. 4, 2019

Vivace Therapeutics patents transcriptional coactivator YAP1/TEAD interaction inhibitors

Dec. 4, 2019

Study shows how individual brain cell types contribute to AD

Dec. 4, 2019

Results form phase II study of galunisertib in MDS

Dec. 4, 2019

89Zr-DFO-MSTP-2109A shows promise as companion diagnostic in patients with mCRPC

Dec. 4, 2019

P. falciparum-induced malaria model created in immunocompromised juvenile mice

Dec. 4, 2019

StemoniX and Atomwise create joint venture that will initially target Rett syndrome

Dec. 4, 2019

Preliminary phase II results for PTG-300 in transfusion-dependent beta-thalassemia

Dec. 4, 2019

Positive topline data from part 1 of adaptive phase III RENEW study of reproxalap

Dec. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...